Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.
Prothrombin and factor X are elevated in multiple sclerosis patients.
Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines.
Recent advances in elucidating KEAP1-NRF2 functions in hematopoietic/immune cells and leukemic cells.
Cutting Edge: ACVRL1 Signaling Augments CD8α+ Dendritic Cell Development.
NG2-glia, More Than Progenitor Cells.
Nicolau syndrome and localized panniculitis: a report of dual diagnoses with an emphasis on morphea profunda-like changes following injection with glatiramer acetate.
An Approach to Enhance Alignment and Myelination of Dorsal Root Ganglion Neurons.
Ultrastructural aspects of mouse nerve-muscle preparation exposed to Bothrops jararacussu and Bothrops bilineatus venoms and their toxins BthTX-I and Bbil-TX: Unknown myotoxic effects.
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design.
CellCept (Product Insert)
Pulmonary eosinophilia associated to treatment with natalizumab.
Metagenomic Analysis of Cerebrospinal Fluid from Patients with Multiple Sclerosis.
Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
A high-fat diet fed during different periods of life impairs steroidogenesis of rat Leydig cells.
Safety, Tolerability, and Immunogenicity of Interferons.
Does robot-assisted gait training improve ambulation in highly disabled multiple sclerosis people? A pilot randomized control trial.
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study.
Cooccurrence of Multiple Sclerosis and Idiopathic Basal Ganglia Calcification.
Serum concentration of CD40L is elevated in inflammatory demyelinating diseases.
β-defensin-2 is a responsive biomarker of IL-17A-driven skin pathology in psoriasis.
SCT: Spinal Cord Toolbox, an open-source software for processing spinal cord MRI data.
Statistical estimation of white matter microstructure from conventional MRI.
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
Inflammatory Th17 Cells Express Integrin αvβ3 for Pathogenic Function.
Pages
« first
‹ previous
…
713
714
715
716
717
718
719
720
721
…
next ›
last »